Dana Hu-Lowe
Corporate Officer/Principal bei ADAGENE INC.
Profil
Dana Hu-Lowe's current job is Vice President-Global Product at Adagene, Inc. Dr. Hu-Lowe's former jobs include Executive Director & Head-Global Product at Turning Point Therapeutics, Inc. and Senior Director-Strategic Alliance & Program at Wellspring Biosciences, Inc. Dr. Hu-Lowe obtained a doctorate degree from the University of Mississippi in 1992 and an undergraduate degree from Beijing Normal University in 1984.
Aktive Positionen von Dana Hu-Lowe
| Unternehmen | Position | Beginn |
|---|---|---|
| ADAGENE INC. | Corporate Officer/Principal | 01.11.2021 |
Ehemalige bekannte Positionen von Dana Hu-Lowe
| Unternehmen | Position | Ende |
|---|---|---|
| TURG POIN | Direktor/Vorstandsmitglied | 01.10.2021 |
| Wellspring Biosciences, Inc. | Corporate Officer/Principal | 01.03.2019 |
Ausbildung von Dana Hu-Lowe
| Beijing Normal University | Undergraduate Degree |
| University of Mississippi | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ADAGENE INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
| Wellspring Biosciences, Inc. |
